Literature DB >> 9802003

Developing family psychoeducational treatments for patients with bipolar and other severe psychiatric disorders. A pathway from basic research to clinical trials.

D J Miklowitz1, J M Hooley.   

Abstract

Developing family treatments for patients with severe and persistent psychiatric disorder begins at the basic research level, through identifying psychosocial variables that have prognostic significance. Treatment protocols informed by this basic research can then be designed, manualized, and piloted. Next, the efficacy of a new treatment is examined, first in a randomized trial and then, if successful, in a community effectiveness study. We describe this treatment development pathway in a population for whom family attributes have prognostic importance: patients with bipolar affective disorder. The methodological complexities of psychosocial treatment studies are many. Moreover, the results of these studies often reflect interactions between treatment, process, and outcome variables.

Entities:  

Mesh:

Year:  1998        PMID: 9802003     DOI: 10.1111/j.1752-0606.1998.tb01098.x

Source DB:  PubMed          Journal:  J Marital Fam Ther        ISSN: 0194-472X


  4 in total

1.  Health Behavior Theories and Research: Implications for Suicidal Individuals' Treatment Linkage and Adherence.

Authors:  Polly Gipson; Cheryl King
Journal:  Cogn Behav Pract       Date:  2012-05

2.  Supportive-expressive dynamic psychotherapy in the community mental health system: a pilot effectiveness trial for the treatment of depression.

Authors:  Mary Beth Connolly Gibbons; Sarah M Thompson; Kelli Scott; Lindsay A Schauble; Tessa Mooney; Donald Thompson; Patricia Green; Mary Jo MacArthur; Paul Crits-Christoph
Journal:  Psychotherapy (Chic)       Date:  2012-09

3.  Engaging women who are depressed and economically disadvantaged in mental health treatment.

Authors:  Nancy K Grote; Allan Zuckoff; Holly Swartz; Sarah E Bledsoe; Sharon Geibel
Journal:  Soc Work       Date:  2007-10

4.  Childhood maltreatment and the course of bipolar disorders among adults: epidemiologic evidence of dose-response effects.

Authors:  Regina Sala; Benjamin I Goldstein; Shuai Wang; Carlos Blanco
Journal:  J Affect Disord       Date:  2014-04-23       Impact factor: 4.839

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.